stimulated HK-2 cell injury model were utilized to examine the renoprotective effect of (NO), cell apoptosis and hypoxia-inducible factor-1 ) changes were analyzed. Results: AZA reduced kidney injury scores and improved renal function by decreasing serum creatinine and NO production, as indicated by Laser Doppler imaging. TUNEL staining presented that AZA reduced apoptotic cells due to attenuated caspase activation and increased Bcl-2/ in vitro Conclusions: The present
Introduction
Acute kidney injury (AKI) has long been a severe threat to kidney disease patients [1] [2] [3] [4] . Among various factors inducing the disorder, renal ischemia-reperfusion (I/R) injury is considered the leading cause [5, 6] . With respect to the inevitable association between kidney transplantation and ischemia followed by reperfusion, patients receiving kidney transplantation tend to be diagnosed with early graft dysfunction due to I/R induced AKI [7, 8] . After ischemic insult and during reperfusion, renal tubular cells sustain oxidative injury are regarded as effective strategies to improve renal I/R injury.
There have been reports about the improvement of renal I/R injury through regulating cellular adaptation under stress conditions including I/R injury via an array of protective genes involved in the process of cell metabolism, angiogenesis, erythropoiesis and anti-I/R injury in different organs, such as brain [11] , heart [12], liver [13] and kidney [14] .
Acetazolamide (AZA) is prescribed to treat edema related diseases such as glaucoma and high mountain sickness. AZA has been reported to effectively induce vessel dilation including the renal circulating system [15] . Moreover, administration of AZA could exert a renoprotective role against contrast induced AKI clinically [16, 17] . The possible protective scavenge of contrast induced reactive oxygen species. The other explanation is vasodilation effect of AZA may ameliorate contrast caused vasoconstriction and regional hypoxia [15, 18] .
In the present study, AZA was found to improve renal function in a murine I/R model in vivo in vitro. AZA also restored renal blood Cellular Physiology and Biochemistry
Cellular Physiology and Biochemistry
I/R insult, left renal artery and vein underwent ligation with a non-traumatic clamp for 30 minutes, then the clamp was released to cause reperfusion, which lasted for 48 hours. In sham group, the same operation was performed without renal vessels occlusion. Mice in AZA treated group was administrated orally with 60mg/kg/day acetazolamide solution for two consecutive days before ischemia insult and during 48h of reperfusion, while corresponding vehicle was given to mice in either sham group or I/R model group. In addition, all underwent right nephrectomy operation and during the operations body temperature was + and K + concentrations in plasma and urine were also monitored by a noninvasively operating blood pressure
Renal function test
Renal function was measured by 2 common parameters: serum creatinine and blood urea nitrogen instructions.
Hematoxylin-eosin and TUNEL staining
analyzed by observing loss of epithelial cells brush border, dilation of tubules, casts production and tubular necrosis as described previously [21, 22] . The scoring grades were determined by a double-blind observer as follows: 0, normal; 1, damage less than 25%; 2, damage between 25% and 50%; 3, damage between 50% injury scoring. The kidney sections were also assayed for apoptosis measurement by using a commercial in situ cell-
Laser Doppler perfusion imaging
Ltd, Devon, UK) before ischemia insult (0), after 30 min of ischemia (30 min) and after 48 h of reperfusion images were analyzed using corresponding MoorLDI v2.1 software (Moor Instruments Ltd, Devon, UK) and the perfusion value was taken and divided by the baseline measurement to give a percentage representing 
Results

Effects of acetazolamide on renal histomorphology and function
To investigate whether AZA could exert an in vivo renoprotective effect, C57BL/6j mice were subjected to sham operation (sham group), or ischemia/reperfusion with treatment of saline (I/R group) or 60mg/kg/day AZA (AZA group). Kidney sections in the I/R group stained with hematoxylin-eosin presented plenty of injuries like loss of epithelial brush border, dilation of tubules, tubular necrosis and cast production (black arrows), while renal 0.38 mg/L and 37.32 basic parameters were shown in Table 1 .
Cellular Physiology and Biochemistry
Cellular Physiology and Biochemistry Ischemia/reperfusion, the leading cause of AKI, commonly occurs in various medical conditions and surgical procedures such as kidney transplantation [35] . Regulation of AKI after I/R injury holds the potential to prevent from early graft dysfunction [7] . In the present study, the renoprotective role of AZA and its underlying mechanism were investigated. AKI, which improved renal histomorphology and function after I/R injury while preventing 2 2 risks of contrast induced AKI by AZA [16, 17, 36] .
As a carbonic anhydrase inhibitor and a diuretic agent, AZA was initially regarded seen in our experiments (Table 1) . Thus, such renoprotective effect may be attributed to has been +/-mice exhibited more severe histologic injury and more impaired renal function after kidney I/R insult. Another report -/-) attenuated myocardial I/R injury through up-regulating its target genes did not participate in the protective effect under I/R against I/R Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry AZA has been reported to dilate both small-and medium-caliber vessels in kidneys and other organs [15, 18, 42, 43] , suggesting a possible role of AZA in increasing renal perfusion rates after I/R insult by vessel dilation. Consistently, AZA was found to restore impaired renal essential mediator of AZA induced vessels dilation, as one report said AZA could increase in the normoxic cell culture system is an important but not levels are regulated: transcriptional regulation and post-translational modulation (mostly from oxygen-mediated degradation is still unclear. We speculated resulting in degradation [46, 47] . It is well known that AZA treatment induces metabolic acidosis via carbonic anhydrase through acidosis mediated leading to its degradation [50, 51] . Pharmacologically investigated in our future work. We should always be aware that although AZA is an ancient diuretic agent affording stage renal failure because complications of AZA such as calcium phosphate kidney stones that AZA administration effectively improved renal function on a patient with acute renal between AZA and acute kidney injury is still disputed, and various patient conditions, AZA dosages and administration periods will result in different outcomes. Although our present study showed that AZA effectively ameliorated mouse renal ischemia-reperfusion injury, question is still remaining whether longer time or higher dose of AZA administration complications of AZA treatment, our suggestion is that AZA can be used to ameliorate contrast or ischemia induced AKI within a short period, however, longer-time usage of this agent should be cautious. In addition, in our future work, a protective role of post-transplant AZA administration against I/R induced AKI still needs to be studied, and by utilizing the animal kidney transplantation model, whether the donor or the recipient should be treated with AZA also needs to be elucidated.
Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry
Conclusion
In conclusion, our present work provided multiple lines of evidence to support that AZA AZA treatment restored mouse renal function against I/R induced AKI.
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